Back to top
more

Fresenius SE & Co. (FSNUY)

(Delayed Data from OTC)

$7.39 USD

7.39
27,676

-0.10 (-1.34%)

Updated Apr 24, 2024 03:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (154 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Balance Sheet

Research for FSNUY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Fresenius SE & Co falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents -99,999 2,896 3,270 2,098 1,852
Receivables NA 7,549 8,509 8,050 8,149
Notes Receivable NA 0 0 0 0
Inventories NA 5,092 4,990 4,506 4,069
Other Current Assets NA 3,721 3,889 3,362 3,025
Total Current Assets NA 19,259 20,658 18,016 17,096
Net Property & Equipment NA 13,611 14,870 13,607 12,664
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 876 1,015 928 940
Intangibles NA 37,764 38,775 34,652 35,399
Deposits & Other Assets NA 2,761 2,705 2,426 2,275
Total Assets NA 80,511 85,138 76,130 75,047
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable NA 0 0 0 0
Accounts Payable NA 2,193 2,521 2,151 2,185
Current Portion Long-Term Debt NA 2,390 4,661 3,317 5,281
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 8,684 9,364 8,491 6,936
Income Taxes Payable NA 228 289 263 260
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 14,390 17,820 15,097 15,550
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 1,758 1,792 1,588 1,588
Convertible Debt NA 517 16,582 541 521
Long-Term Debt NA 19,486 3,087 18,673 17,516
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 4,365 4,394 4,311 3,779
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 46,566 50,488 46,404 45,277
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 593 660 636 624
Capital Surplus NA 4,555 4,763 4,560 4,468
Retained Earnings NA 0 0 0 0
Other Equity NA 28,797 29,227 24,530 24,678
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 33,945 34,651 29,726 29,770
Total Liabilities & Shareholder's Equity NA 80,511 85,138 76,130 75,047
Total Common Equity 0 33,945 34,651 29,726 29,770
Shares Outstanding 2,234.00 2,252.90 2,233.80 2,225.20 2,225.20
Book Value Per Share 0.00 15.07 15.51 13.36 13.38

Fiscal Year End for Fresenius SE & Co falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 -99,999 1,192 2,694 2,491
Receivables NA NA 4,529 8,407 8,447
Notes Receivable NA NA 0 0 0
Inventories NA NA 2,898 5,472 5,310
Other Current Assets NA NA 40,179 4,477 4,256
Total Current Assets NA NA 48,798 21,050 20,504
Net Property & Equipment NA NA 9,751 13,953 13,707
Investments & Advances NA NA 0 0 0
Other Non-Current Assets NA NA 0 0 0
Deferred Charges NA NA 570 991 959
Intangibles NA NA 20,014 38,344 37,885
Deposits & Other Assets NA NA 779 2,725 2,885
Total Assets NA NA 81,987 83,321 82,172
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA NA 0 0 0
Accounts Payable NA NA 1,325 2,191 2,234
Current Portion Long-Term Debt NA NA 2,318 4,559 4,528
Current Portion Capital Leases NA NA 0 0 0
Accrued Expenses NA NA 5,778 9,401 9,065
Income Taxes Payable NA NA 224 424 356
Other Current Liabilities NA NA 21,889 19 0
Total Current Liabilities NA NA 31,769 17,509 17,087
Mortgages NA NA 0 0 0
Deferred Taxes/Income NA NA 784 1,788 1,819
Convertible Debt NA NA 9,195 0 0
Long-Term Debt NA NA 2,665 19,188 21,251
Non-Current Capital Leases NA NA 0 0 0
Other Non-Current Liabilities NA 2,576 4,496 1,451
Minority Interest (Liabilities) NA NA 0 0 0
Total Liabilities NA NA 49,028 49,049 47,637
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA NA 0 0 0
Common Stock (Par) NA NA 613 614 604
Capital Surplus NA NA 4,707 4,714 4,638
Retained Earnings NA NA 0 0 0
Other Equity NA NA 27,639 28,944 29,292
Treasury Stock NA NA 0 0 0
Total Shareholder's Equity NA NA 32,959 34,271 34,535
Total Liabilities & Shareholder's Equity NA NA 81,987 83,321 82,172
Total Common Equity 0 0 32,959 34,271 34,535
Shares Outstanding 2,234.00 2,234.00 2,234.00 2,234.00 2,234.00
Book Value Per Share 0.00 0.00 14.75 15.34 15.46